Arbutus Biopharma Corp (NASDAQ:ABUS)
| 2.90 BATS BZX Real-Time Price As of 10:30am ET |  -0.205 / -6.61%Today’s Change | 0.82 Today|||52-Week Range 4.75 | +4.14% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Biotechnology | MARKET CAP $201.9M |
Company Description
Arbutus Biopharma Corp. engages in discovering, developing and commercializing a cure for patients suffering from chronic Hepatitis B virus infection. The company is headquartered in Burnaby, Canada.
Contact Information
Arbutus Biopharma Corp. 8900 Glenlyon Parkway Burnaby British Columbia V5J 5J8 |
Employees
Shareholders
| Individual stakeholders | 32.52% |
| Mutual fund holders | 3.76% |
| Other institutional | 29.34% |
Top Executives
| There are no executives to display. |
